Dr. Branislav Schifferdecker, MD

Dr. Schifferdecker practices at Oklahoma Heart Hospital North in Oklahoma City, Oklahoma, part of Oklahoma Heart Hospital.

Dr. Schifferdecker's NPI, 1013973304, was assigned on April 25, 2006. Dr. Schifferdecker holds Oklahoma license 24815.

Dr. Schifferdecker's primary practice is Oklahoma Heart Hospital North, at 4050 West Memorial Road, Oklahoma City, OK 73120 in Oklahoma County. The practice phone is (405) 608-3200.

Dr. Schifferdecker's primary practice is Oklahoma Heart Hospital North in Oklahoma City, Oklahoma, part of Oklahoma Heart Hospital. Dr. Schifferdecker is also affiliated with Mercy Hospital Oklahoma City. The medical group on file is Oklahoma Heart Hospital. Dmand AI also links Dr. Schifferdecker to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schifferdecker practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Schifferdecker's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Schifferdecker's licenses on file in 2 states: Oklahoma and Massachusetts.

CMS data shows 13,318 Medicare services from Dr. Schifferdecker across 45 procedure codes in 2024, for 4,464 Medicare patients. Medicare paid $581,960 for them.

CMS counts 4,464 Medicare patients who saw Dr. Schifferdecker in 2024. The largest group is 65 to 74, with 1,760 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schifferdecker's median patient age at 74, with 51% women.

In 2024, Dr. Schifferdecker wrote 25,718 Medicare Part D claims for 2,334 patients. 83% of them were for generic drugs. CMS names the drug for 25,200 of them, across 107 drugs with 11 or more claims each, at $3,981,836 in total drug cost. In 2023, CMS named 22,553 claims across 108 drugs.

Dr. Schifferdecker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schifferdecker as offering telehealth. CMS counts 95 procedures of coronary angioplasty and stenting by Dr. Schifferdecker, more than 96% of the clinicians it reports for that procedure.

CMS Open Payments shows 835 general payments to Dr. Schifferdecker from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $13,074.